Signant Health Brings eConsent Solution to China

Article

Applied Clinical Trials

Signant Health has been selected to provide electronic informed consent for a significant neuroscience study by the Shanghai Mental Health Center. This investigator-led Schizophrenia trial will enroll hundreds of patienta and implement Signant’s TrialConsent solution in China.

To learn more, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.